An obligatory role for lung infiltrating B cells in the immunopathogenesis of obliterative airway disease induced by antibodies to MHC class I molecules

American Journal of Transplantation

Volumn 12, Issue 4, 2012, Pages 867-876

  Fukami, N ^a   Ramachandran, S ^a   Takenaka, M ^a   Weber, J ^a   Subramanian, V ^a   Mohanakumar, T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti MHC; Antibodies; Autoimmunity; B cell; Cytokines; IL 17; OAD

Indexed keywords

ALPHA TUBULIN; COLLAGEN TYPE 5; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY OBSTRUCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BRONCHIOLITIS OBLITERANS; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM HYPERPLASIA; GERMINAL CENTER; IMMUNOPATHOGENESIS; LUNG ALVEOLUS CELL; LUNG FIBROSIS; LUNG TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MALE; METAPLASIA; MOUSE; NONHUMAN; OBLITERATIVE AIRWAY DISEASE; PRIORITY JOURNAL; SMALL AIRWAY DISEASE; SPLEEN; TH17 CELL;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; B-LYMPHOCYTES; BRONCHIOLITIS OBLITERANS; FIBROSIS; FLOW CYTOMETRY; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOGLOBULIN G; INTERLEUKIN-17; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES;

EID: 84859424180     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03917.x     Document Type: Article

References (35)

1. Lange W. Uber eine eigenthumbiche erkankung der kleinen broncheim and bronchiolen. Deutsche Arch Klin Med 1901; 70: 342-364.
2. Jain R, Hachem RR, Morrell MR, et al. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant 2010; 29: 531-537.
3. Sundaresan RS, Trulock EP, Mohanakumar T, Cooper JD, Patterson GA. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg 1995; 60: 1341-1347.
4. Valentine VG, Robbins RC, Berry GJ, et al. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 1996; 15: 371-383. (Pubitemid 26144508)
5. Smith MA, Sundaresan S, Mohanakumar T, et al. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg 1998; 116: 812-820. (Pubitemid 28499176)
6. Griffith BP, Paradis IL, Zeevi A, et al. Immunologically mediated disease of the airways after pulmonary transplantation. Ann Surg 1988; 208: 371-378.
7. Boehler A, Kesten S, Weder W, Speich R. Bronchiolitis obliterans after lung transplantation: A review. Chest 1998; 114: 1411-1426. (Pubitemid 28527420)
8. Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Resp Crit Care Med 2003; 166: 440-444.
9. Reznik SI, Jaramillo A, Zhang L, Patterson GA, Cooper JD, Mohanakumar T. Anti-HLA antibody binding to hla class I molecules induces proliferation of airway epithelial cells: A potential mechanism for bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg 2000; 119: 39-45. (Pubitemid 30046311)
10. Bharat A, Narayanan K, Street T, et al. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation 2007; 83: 150-158. (Pubitemid 46185205)
11. Fukami N, Ramachandran S, Saini D, et al. Antibodies to MHC class I induce autoimmunity: Role in the pathogenesis of chronic rejection. J Immunol 2009; 182: 309-318.
12. Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007; 8: 345-350. (Pubitemid 46745409)
13. Noorchashm H, Reed AJ, Rostami SY, et al. B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J Immunol 2006; 177: 7715-7722. (Pubitemid 44846287)
14. Lindell DM, Berlin AA, Schaller MA, Lukacs NW. B cell antigen presentation promotes Th2 responses and immunopathology during chronic allergic lung disease. PLoS One 2008; 3: e3129.
15. Hsu HC, Yang P, Wang J, et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 2008; 9: 166-175.
16. Tian J, Zekzer D, Lu Y, Dang H, Kaufman DL. B cells are crucial for determinant spreading of T cell autoimmunity among beta cell antigens in diabetes-prone nonobese diabetic mice. J Immunol 2006; 176: 2654-2661. (Pubitemid 43201718)
17. Yan J,Harvey BP, Gee RJ, ShlomchikMJ, Mamula MJ. B cells drive early T cell autoimmunity in vivo prior to dendritic cell-mediated autoantigen presentation. J Immunol 2006; 177: 4481-4487. (Pubitemid 44469778)
18. Lund FE. Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol 2008; 20: 332-338.
19. Goers TA, Ramachandran S, Aloush A, Trulock E, Patterson GA, Mohanakumar T. De novo production of K-alpha 1 tubulin-specific Abs: Role in chronic lung allograft rejection. J Immunol 2008; 180: 4487-4494.
20. Jaramillo A, Smith MA, Phelan D, et al. Temporal relationship between the development of anti-HLA antibodies and the development of bronchiolitis obliterans syndrome after lung transplantation. Transplant Proc 1999; 31: 185-186. (Pubitemid 29127419)
21. Hachem RR. Lung allograft rejection: Diagnosis and management. Curr Opin Organ Transplant 2009; 14: 477-482.
22. Grossman EJ, Shilling RA. Bronchiolitis obliterans in lung transplantation: The good, the bad, and the future. Transl Res 2009; 153: 153-165.
23. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002; 3: 944-950. (Pubitemid 35154008)
24. Nozaki T, Rosenblum JM, Ishii D, Tanabe K, Fairchild RL. CD4 T cell-mediated rejection of cardiac allografts in B cell-deficient mice. J Immunol 2008; 181: 5257-5263.
25. Bosio CM, Elkins KL. Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity. Infect Immun 2001; 69: 194-203. (Pubitemid 32040947)
26. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25: 821-852. (Pubitemid 46697925)
27. Korn T, Mitsdoerffer M, Croxford AL, et al. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A 2008; 105: 18460-18465.
28. Serada S, Fujimoto M, Mihara M, et al. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2008; 105: 9041-9046.
29. Fenton RR, Molesworth-Kenyon S, Oakes JE, Lausch RN. Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation. Invest Ophthalmol Vis Sci 2002; 43: 737-743. (Pubitemid 34184491)
30. Wolters PJ, Wray C, Sutherland RE, et al. Neutrophil-derived IL-6 limits alveolar barrier disruption in experimental ventilator-induced lung injury. J Immunol 2009; 182: 8056-8062.
31. Fielding CA, McLoughlin RM, McLeod L, et al. IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. J Immunol 2008; 181: 2189-2195.
32. Zheng L, Walters EH, Ward C, et al. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation. Thorax 2000; 55: 53-59. (Pubitemid 30248779)
33. McAllister F, Henry A, Kreindler JL, et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: Implications for airway inflammation in cystic fibrosis. J Immunol 2005; 175: 404-412. (Pubitemid 40884344)
34. Huang F, Kao CY, Wachi S, Thai P, Ryu J, Wu R. Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells. J Immunol 2007; 179: 6504-6513.
35. Roussel L, Houle F, Chan C, et al. IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol 2010; 184: 4531-4537.